“…In accordance with previous studies using CGS analysis (e.g. Enge et al 2020 ), participants’ DRD2-CGS was calculated by adding the numbers of alleles previously associated with lower dopaminergic neurotransmission, as outlined above, assuming a linear model. In short, the number of T alleles of the rs1800497 (TT: 6, TC: 46, CC: 103; HWE: χ 2 (1) = 0.09, p = .762), the number of T alleles of the rs2283265 (TT: 4, TG: 40, GG: 111; HWE: χ 2 (1) = 0.03, p = .862), the number of C alleles of the rs6277 (TT: 45, TC: 78, CC: 32; HWE: χ 2 (1) = 0.03, p = .866), the number of T alleles of the rs12364283 (TT: 126, TC: 27, CC: 2; HWE: χ 2 (1) = 0.16, p = .688), the number of C alleles of the rs2242592 (TT: 76, TC: 66, CC: 13; HWE: χ 2 (1) = 0.06, p = .802) and the number of T alleles of the rs4648317 (TT: 3, TC: 37, CC: 115; HWE: χ 2 (1) = 0.00, p = .992) were added, resulting in a CGS ranging from 0 to 12 (Table 1 ).…”